EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Presentation, management, and outcomes of norovirus in adult and pediatric solid organ and hematopoietic stem cell transplant recipients: A multicenter, retrospective study

Michelle Callegari iD, Lara A Danziger-Isakov iD, Anne Rose, Daniel Kaul iD, Kelly Shaffer iD, Pearlie P Chong iD, Diana Florescu iD, Kaci German, Robin Avery iD, M Hong Nguyen iD, Brett Wildfeuer, Marian G Michaels iD und 5 weitere

Transplant Infectious Disease · 2024-06 · 26 (3)

DOI: 10.1111/tid.14270 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Transplant Infectious Disease, online erschienen am 25.03.2024. Verfasst von Michelle Callegari und 16 weiteren Autor:innen. Beteiligte Einrichtung: Divisions of Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Caliciviridae Infections, Norovirus, Hematopoietic Stem Cell Transplantation, Diarrhea. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases, NIAID NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Norovirus (NoV) can cause chronic relapsing and remitting diarrhea in immunocompromised patients. Few multicenter studies have described the clinical course, outcomes, and complications of chronic NoV in transplant recipients.

Methods

A multicenter retrospective study of adult and pediatric SOT and HSCT recipients diagnosed with NoV between November 1, 2017, and February 28, 2021. Data were obtained from electronic medical records (EMR) and entered into a central REDCap database. Descriptive statistics were calculated.

Results

A total of 280 NoV+ patients were identified across eight sites. The majority were adults (74.1%) and SOT recipients (91.4%). Initial diagnosis of NoV occurred a median of 36 months post‐Tx (IQR [15.0, 90.0]). Most NoV cases had >3 diarrheal episodes daily (66.0%), nausea and vomiting (60.1%). Duration of diarrhea varied greatly (median = 10 days, mean = 85.9 days, range (1, 2100)). 71.3% were hospitalized. Adjustment of immunosuppression, including reduction and discontinuation of mToR inhibitor, CNI, and/or MMF, was the most common management intervention for NoV. Other therapies resulted only in temporary improvement. Four patients died within 30 days and three others died by 180 days postdiagnosis. Clinically significant renal dysfunction was observed in 12.5% by 30 days and 21.4% by 180 days post‐NoV diagnosis.

Conclusion

In HSCT and SOT patients, NoV frequently resulted in severe symptoms, prolonged diarrhea (30% persistent with diarrhea for >30 days), and clinically significant renal dysfunction (up to 21% of patients). Utilized therapies did not reliably result in the resolution of infection demonstrating the need for more effective treatment. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caliciviridae InfectionsNorovirusHematopoietic Stem Cell TransplantationDiarrheaOrgan TransplantationImmunocompromised HostHumansRetrospective StudiesMaleFemaleAdultChildMiddle AgedAdolescentTransplant RecipientsChild, PreschoolYoung AdultAgedImmunosuppressive AgentsGastroenteritisInfant

Stichwörter der Autor:innen

HSCTdiarrheanorovirusrenal insufficiencytransplant

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Divisions of Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA.
  • Division of Infectious Disease, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan, USA.
  • Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Infectious Diseases Division, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Division of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland, USA.

ORCID-Profile: Michelle Callegari, Lara A Danziger-Isakov, Daniel Kaul, Kelly Shaffer, Pearlie P Chong, Diana Florescu, Robin Avery, M Hong Nguyen, Marian G Michaels, Michael Green, Lihui Zhao, Amna Daud, Michael G Ison

Förderung

  • National Institute of Allergy and Infectious Diseases
  • NIAID NIH HHS
  • NIH HHS
  • HHS
  • National Institutes of Health
  • U.S. Department of Health and Human Services

Zitieren

APA

Callegari, M., Danziger-Isakov, L. A., Rose, A., Kaul, D., Shaffer, K., Chong, P. P., Florescu, D., German, K., Avery, R., Nguyen, M. H., Wildfeuer, B., Michaels, M. G., Green, M., Guo, K., Zhao, L., Daud, A., & Ison, M. G. (2024). Presentation, management, and outcomes of norovirus in adult and pediatric solid organ and hematopoietic stem cell transplant recipients: A multicenter, retrospective study. Transplant Infectious Disease, 26(3). https://doi.org/10.1111/tid.14270

Vancouver

Callegari M, Danziger-Isakov LA, Rose A, Kaul D, Shaffer K, Chong PP, et al. Presentation, management, and outcomes of norovirus in adult and pediatric solid organ and hematopoietic stem cell transplant recipients: A multicenter, retrospective study. Transplant Infectious Disease. 2024;26(3). doi:10.1111/tid.14270

BibTeX
@article{Callegari2024,
  author = {Callegari, Michelle and Danziger-Isakov, Lara A and Rose, Anne and Kaul, Daniel and Shaffer, Kelly and Chong, Pearlie P and Florescu, Diana and German, Kaci and Avery, Robin and Nguyen, M Hong and Wildfeuer, Brett and Michaels, Marian G and Green, Michael and Guo, Kexin and Zhao, Lihui and Daud, Amna and Ison, Michael G},
  title = {Presentation, management, and outcomes of norovirus in adult and pediatric solid organ and hematopoietic stem cell transplant recipients: A multicenter, retrospective study},
  journal = {Transplant Infectious Disease},
  year = {2024},
  volume = {26},
  number = {3},
  doi = {10.1111/tid.14270}
}
Kostenlos starten →